Nautilus Biotechnolgy (NAUT) Earnings Analysis

Nautilus Biotechnolgy (NAUT) next reports earnings on 2026-07-28, consensus EPS -0.135 USD. Last quarter (2026-02-26) it beat with EPS -0.11 USD vs -0.14 USD est (+21.4%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E -3.70.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does NAUT next report earnings?

Next earnings date2026-07-28
Consensus EPS estimate-0.135 USD
Revenue estimate0.00B

NAUT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-26-0.11 USD-0.14 USD+21.4%Beat
2025-10-27-0.11 USD-0.15 USD+26.7%Beat
2025-07-31-0.12 USD-0.155 USD+22.6%Beat
2025-02-26-0.14 USD-0.16 USD+12.5%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

NAUT valuation and analyst view

Trailing P/E-3.70
Trailing EPS-0.45078 USD
Price / book1.49
Dividend yield0.00%
Market cap0.22B
Analyst consensusBuy (3 buy / 1 hold / 1 sell)

Related research pages

Frequently asked questions

When is Nautilus Biotechnolgy (NAUT)'s next earnings date?

Nautilus Biotechnolgy is next scheduled to report on 2026-07-28, with a consensus EPS estimate of -0.135 USD and revenue estimate of 0.00B.

Did NAUT beat earnings last quarter?

In its 2026-02-26 report, NAUT posted EPS of -0.11 USD versus a -0.14 USD estimate — a beat of 21.4%.

What is NAUT's earnings track record?

Over the last 4 reported quarters with consensus data, NAUT beat estimates 4 times (100%).

What is NAUT's current P/E ratio and EPS?

NAUT trades at a trailing P/E of -3.70 on trailing EPS of -0.45078452458661794 USD.

What do analysts rate NAUT?

Analyst consensus is "Buy" across 5 ratings (0 strong buy, 3 buy, 1 hold, 1 sell, 0 strong sell).